www.leagle.com/decision/1995235234Conn1_1235/TOROSYAN v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
ANUSHAVAN G. TOROSYAN v. BOEHRINGER INGELHEIM
PHARMACEUTICALS, INC. PETERS, C. J. The principal issue in this appeal is
whether there was ...
Feb 20, 2015 ... See FTC v. Boehringer Ingelheim Pharm., Inc., 286 F.R.D. 101 (D.D.C.. 2012). ...
patented pharmaceutical drugs that earn hundreds of millions of dollars in .... FTC
v. Grolier Inc., 462 U.S. 19, 27-28 (1983); In re Murphy,. 560 F.2d ... omitted);
accord 8 CHARLES ALAN WRIGHT ET AL., FEDERAL. PRACTICE ...
Feb 10, 2016 ... Medical writing support was provided by Lori Kornberg (INC Research ... and is a
consultant for Merck, Tarsa Pharmaceuticals, and Radius Health. ... from Amgen,
Boehringer Ingelheim, Immunodiagnostics, Lilly, Merck, ... Cummings SR, San
Martin J, McClung MR, et al. .... Ma YL, Zeng Q, Donley DW, et al.
Comparisons between treatment arms (acamprosate vs placebo) were made by
the .... Tiihonen et al found similar benefit in 62 alcoholic patients. ... served in
advisory/consultative relationships with Boehringer Ingelheim and Pfizer. ... Inc,
Transcept Pharmaceuticals, Vanda Pharmaceuticals Inc, Wyeth-Ayerst
May 17, 2007 ... We imaged T cell dynamics in the DC-rich spleen (Kraal et al., 1986), ..... #20)
was kindly provided by Boehringer-Ingelheim Pharmaceuticals, Inc. (Cywin et al.,
2007). ... A-11018), donkey anti-sheep IgG (Molecular Probes, A-21099), or
avidin ... We thank M. Nussenzweig for the CD11c<sup>+</sup>-YFP mice; and V.
AZA 5-2-2, p = 0.0021; AZA 5 vs. AZA 7, p ... Table 3. Assigned scores in lower-
risk patients based on the prognostic score described by Garcia-Manero et al.
Aug 4, 2015 ... It appears that Boehringer Ingelheim abandoned development of sICAM-1 as a
.... The variants with V and LAPG at the N-terminus had the longest ... Following
the 2001 anthrax attack (Borio et al., 2001; Jernigan et al., 2001, ..... goat anti-
DPP4 IgG and reported with donkey anti-goat IgG labelled with HRP.
Nov 23, 2015 ... S1, C and D; Chernyshev et al., 2015). ..... (1:500; 10782-2-AP; Proteintech
Group, Inc.), mouse anti–TIA-1 related protein (TIAR; 1:500; BD), ... Thermo
Fisher Scientific), and donkey anti–mouse IgG Alexa Fluor 647 (1:750; A31571;
.... B. Strobel is an employee of Boehringer Ingelheim Pharma GmbH & Co.
E-selectin, endothelial P-selectin, and ICAM-1 were stained as described by
Okada et al, with ... Biotinylated F(ab′)2 fragment of donkey anti-mouse IgG was
used as the .... Main time effect (30 minutes vs 1 hour vs 2 hours) was also
significant .... PhD, is employed by Boehringer Ingelheim Pharmaceuticals, Inc,
which has ...
In the first set of experiments, 21 8-week-old mice were exposed to a high-fat diet
(HFD; Research Diets, Inc., New ... Before the start of the linagliptin (Boehringer
Ingelheim Pharma GmbH & Co. .... buffer containing 3% normal donkey serum
and 0.25% Triton-X. The sections ..... Darsalia V,; Mansouri S,; Ortsäter H,; et al.